On track for August 15, 2025 FDA PDUFA goal date TNX-102 SL is a non-opioid analgesic; if approved, TNX-102 SL...
NEW YORK, March 24, 2025 (GLOBE NEWSWIRE) -- “Tren-Max is the safe and legal steroid alternative to Trenbolone Acetate" Our...
– Continued progress in pivotal, adaptive Phase 3 clinical trial (the “MIRACLE” trial) toward first subject treated, on track to...
Augustine Therapeutics raises oversubscribed EUR 78 million / USD 85 million Series A financing round Novo Holdings and Jeito Capital...
Company Appoints Medical Device and Healthcare Industry Veteran with 20 Years of ExperienceEXTON, Pa., March 24, 2025 (GLOBE NEWSWIRE) --...
Multiple datasets support continued development of ProMIS’ antibody therapeutics and vaccines that selectively target toxic misfolded proteins to treat neurodegenerative...
AURORA, Colo., March 22, 2025 (GLOBE NEWSWIRE) -- Arialief is a unique nerve pain and discomfort relief supplement with natural...
A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including new semaglutide cardiovascular data and...
NATCHITOCHES, La., March 21, 2025 /PRNewswire/ -- "AI works 120 million times faster than the human brain," according to Dr....
Addition Bolsters Healthtech Pioneer's Innovation Trajectory; Accelerates Growth, Diversifies Offerings and Expands Global Reach SAN DIEGO, March 20, 2025 /PRNewswire/...
Nataliya Agafonova Nataliya Agafonova, M.D., Chief Medical Officer, Longeveron Planned single, pivotal Phase 2/3 clinical trial, if positive, acceptable for...
University of Oxford spinout accelerates commercial expansion in the US of its innovative stroke AI imaging solution, with its demonstrated...
Enhancing Precision and Innovation in Neurosurgical Robotics Across China ZHUBEI, March 19, 2025 /PRNewswire/ -- Brain Navi Biotechnology, a leading...
Olio Labs Identifies Why Women Experience Stronger Side Effects from GLP-1 DrugsThe Company's AI-Powered Combination Design Engine (CoDE) Maps Biological...
North Bergen, New Jersey--(Newsfile Corp. - March 19, 2025) - Apollo Biowellness, Inc. formerly known as Resonate Blends, Inc. (OTC...
Founded by Former NHL Player and mental health advocate Daniel Carcillo, the Portland center is the first of its kind...
FDA & EMA approvals for rare genetic diseases are fast and require clinical studies with small number of patients Ramat...
New Novartis Phase III data demonstrate meaningful efficacy and safety results of intrathecal onasemnogene abeparvovec in broad patient population with...
LAKELAND, Fla., March 19, 2025 (GLOBE NEWSWIRE) -- Lipozem is a weight loss supplement crafted to support burning fat without...
NEW YORK, March 18, 2025 /PRNewswire/ -- DarwinHealth is proud to have been named to Fast Company's prestigious list of the...